We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

AI in drug discovery discussed at AICON’25 conference by industry experts, highlighting transformative role in pharmaceutical ...

Happy V-Day! Gorge on heart-shaped chocolate and ponder the implications of RFK Jr. being sworn in as health secretary. Today, we talk about that, as well as new cancer data from Corbus Pharma, Europe ...

By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...

Amid the federal funding uncertainty for health and sciences, local life science leaders say this could be a moment for ...

A federal judge will soon decide whether to dismiss a lawsuit against UnitedHealth Group alleging that the company and its ...

Kilroy Realty has opened a second phase of its Oyster Point life sciences campus — but it's attracting financial and tech ...

Biotech firm Phytome Life Sciences plans to establish a headquarters in Saudi Arabia in a bid to accelerate commercialization ...

AbbVie ( ABBV 0.61%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

A joint report by the Institute for Deep Tech Innovation (DEEP) at ESMT Berlin and the Bertelsmann Stiftung highlights Germany’s immense innovation potential in the biotech sector. However, this ...

It's crunch time for biotech projects started on a bet that the industry would shake off its multiyear malaise.

The Port of East London was a hive of activity this weekend with residents coming from far and wide to learn more about the SA Agulhas II.